查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611028

美国医疗设备製造商市场规模、份额和趋势分析报告：按应用、细分市场预测，2025-2030年

U.S. Medical Device Manufacturers Market Size, Share & Trends Analysis Report By Application, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10个工作天内

价格

美国医疗设备製造商市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年美国医疗设备製造商市场规模将达3,601亿美元，2025年至2030年复合年增长率为5.9%。

该区域市场主要是由该国高额医疗保健支出推动的。预计老年人口的增加和慢性病盛行率的上升也将促进预测期内的市场成长。

COVID-19 大流行引发了对手套、注射器、口罩、个人防护套件、红外线体温计、脉动式血氧监测仪系统和检测套组等医疗消耗品和病患辅助用具的需求急剧增加。这为现有参与者和新进入者创造了巨大的商机。然而，疫情也导致减重手术、关节重建手术和整容手术等择期手术大幅减少，限制了上述手术中使用的医疗设备的成长。从 2021 年中开始，由于政府为重启择期手术做出了积极努力，市场预计将復苏。

在美国，医疗设备研发投入不断加大，尖端技术采用率较高，为医疗设备製造商创造了理想的商业环境。该国越来越多地采用微创手术也推动了市场的发展。此外，由于意外事故以及久坐生活方式引起的疾病导致的病例增加预计将在预测期内推动市场成长。

美国有优惠的报销政策，例如美国的医疗保险制度。波士顿科学公司 (Boston Scientific) 与医疗保险和医疗补助服务中心 (CMS) 合作，为 C 代码涵盖的流动支付分类 (APC) 范围内的所有设备提供报销。儘管这种有利的报销结构预计将促进市场成长，但法规不断变化的性质可能会受到突然修订的影响，这可能会对市场产生重大影响。

美国医疗设备製造商市场报告亮点

  • 其他细分市场领先市场，占 2024 年销售额的 35.7%。此细分市场主要包括用于体外诊断、医学影像、牙科、耳鼻喉 (ENT)、伤口护理和一般外科的设备。
  • 预计心臟病设备在预测期内的复合年增长率将达到 7.7%，是最快的。
  • 根据 CDC 2023 年 5 月发表的报导，心血管疾病每 33 秒就会导致 1 人死亡，医疗设备的市场需求庞大。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国医疗设备製造商市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国医疗设备製造商市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国医疗设备製造商市场：应用预估及趋势分析

  • 2024年及2030年应用市场占有率
  • 细分仪表板
  • 美国医疗设备製造商按应用市场前景
  • 2018-2030年市场规模及预测及趋势分析
    • 整形外科设备
    • 心血管设备
    • 神经病学设备
    • 药物输送装置
    • 眼科设备
    • 肾臟科/泌尿系统设备
    • 其他的

第五章竞争状况

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 2024年主要企业市场占有率分析
    • Stryker
    • Cardinal Health
    • Eli Lily and Company
    • Intuitive Surgical
    • Edwards Lifesciences Corporation
    • BD
    • Danaher
    • 3M
    • Abbott
    • Baxter
    • B. Braun SE
    • GE HealthCare
    • Johnson &Johnson Services, Inc.
    • Medtronic
    • Boston Scientific Corporation
Product Code: GVR-3-68038-032-3

U.S. Medical Device Manufacturers Market Growth & Trends:

The U.S. medical device manufacturers market size is expected to reach USD 360.1 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The regional market is significantly driven by the high healthcare expenditure of the country. The increasing geriatric population coupled with the rising prevalence of chronic diseases is also expected to augment the market growth over the forecast period.

The COVID-19 pandemic triggered a drastic rise in demand for medical consumables and patient aids, such as gloves, syringes, masks, PPE kits, infrared thermometers, pulse oximeter, testing kits, etc. This resulted in an immense opportunity for the existing players as well as new entrants. However, the pandemic also resulted in a massive reduction in elective procedures, such as bariatric surgeries, joint replacement surgeries, cosmetic surgeries, etc., thus restricting the growth of medical devices used in the aforementioned procedures. The market recovery can be expected from mid-2021 onwards with favorable government initiatives to re-launch elective procedures.

Growing investments in medical device R&D along with the high adoption rate of advanced technology in the U.S., create the perfect business environment for medical device manufacturers in the country, providing them with lucrative opportunities to accelerate their business operations. Increasing adoption of minimally invasive surgeries in the country is also driving the market. In addition, rising cases of accidental injuries coupled with diseases caused due to sedentary lifestyle will propel the market growth over the forecast period.

The U.S. has favorable reimbursement policies such as the U.S. Medicare system. Boston Scientific Corp., in association with the Centers for Medicare and Medicaid Services (CMS), offers reimbursement for all devices that fall under Ambulatory Payment Classifications (APCs), covered under C-codes. These favorable reimbursement structures are expected to fuel market growth; however, the ever-evolving nature of regulations may lead to abrupt amends, which may significantly impact the market.

U.S. Medical Device Manufacturers Market Report Highlights:

  • The others segment led the market and accounted for 35.7% of the revenue in 2024. The segment primarily comprises devices used in IVD diagnostics, medical imaging, dental, ear-nose-and-throat (ENT), wound care, and general surgery.
  • Cardiology devices are expected to register the fastest CAGR of 7.7% over the forecast period.
  • Heart diseases are one of the leading causes of mortality in the U.S. According to a CDC article published in May 2023, the high mortality, with one death due to cardiovascular disease every 33 seconds, creates a substantial market demand for innovative medical devices that can contribute to the prevention, early diagnosis, & effective treatment of heart-related conditions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in the U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Medical Device Manufacturers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing geriatric population
      • 3.2.1.2. High adoption of minimally invasive procedures
      • 3.2.1.3. Increase in the number of sports and road accidents
      • 3.2.1.4. Increasing geographic reach of market players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Increase in the number of product recalls
      • 3.2.2.2. Social and ethical issues
      • 3.2.2.3. Slow approval procedures
  • 3.3. U.S. Medical Device Manufacturers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. U.S. Medical Device Manufacturers Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Medical Device Manufacturers Market by Application Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Orthopedic Devices
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Cardiovascular Devices
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Neurology Devices
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.4. Drug Delivery Devices
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.5. Ophthalmic Devices
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.6. Nephrology and Urology Devices
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.7. Others
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 5.2. Company/Competition Categorization
  • 5.3. Vendor Landscape
    • 5.3.1. Key company market share analysis, 2024
    • 5.3.2. Stryker
      • 5.3.2.1. Company overview
      • 5.3.2.2. Financial performance
      • 5.3.2.3. Product benchmarking
      • 5.3.2.4. Strategic initiatives
    • 5.3.3. Cardinal Health
      • 5.3.3.1. Company overview
      • 5.3.3.2. Financial performance
      • 5.3.3.3. Product benchmarking
      • 5.3.3.4. Strategic initiatives
    • 5.3.4. Eli Lily and Company
      • 5.3.4.1. Company overview
      • 5.3.4.2. Financial performance
      • 5.3.4.3. Product benchmarking
      • 5.3.4.4. Strategic initiatives
    • 5.3.5. Intuitive Surgical
      • 5.3.5.1. Company overview
      • 5.3.5.2. Financial performance
      • 5.3.5.3. Product benchmarking
      • 5.3.5.4. Strategic initiatives
    • 5.3.6. Edwards Lifesciences Corporation
      • 5.3.6.1. Company overview
      • 5.3.6.2. Financial performance
      • 5.3.6.3. Product benchmarking
      • 5.3.6.4. Strategic initiatives
    • 5.3.7. BD
      • 5.3.7.1. Company overview
      • 5.3.7.2. Financial performance
      • 5.3.7.3. Product benchmarking
      • 5.3.7.4. Strategic initiatives
    • 5.3.8. Danaher
      • 5.3.8.1. Company overview
      • 5.3.8.2. Financial performance
      • 5.3.8.3. Product benchmarking
      • 5.3.8.4. Strategic initiatives
    • 5.3.9. 3M
      • 5.3.9.1. Company overview
      • 5.3.9.2. Financial performance
      • 5.3.9.3. Product benchmarking
      • 5.3.9.4. Strategic initiatives
    • 5.3.10. Abbott
      • 5.3.10.1. Company overview
      • 5.3.10.2. Financial performance
      • 5.3.10.3. Product benchmarking
      • 5.3.10.4. Strategic initiatives
    • 5.3.11. Baxter
      • 5.3.11.1. Company overview
      • 5.3.11.2. Financial performance
      • 5.3.11.3. Product benchmarking
      • 5.3.11.4. Strategic initiatives
    • 5.3.12. B. Braun SE
      • 5.3.12.1. Company overview
      • 5.3.12.2. Financial performance
      • 5.3.12.3. Product benchmarking
      • 5.3.12.4. Strategic initiatives
    • 5.3.13. GE HealthCare
      • 5.3.13.1. CompanOverviewew
      • 5.3.13.2. Financial performance
      • 5.3.13.3. Product benchmarking
      • 5.3.13.4. Strategic initiatives
    • 5.3.14. Johnson & Johnson Services, Inc.
      • 5.3.14.1. CompanOverviewew
      • 5.3.14.2. Financial performance
      • 5.3.14.3. Product benchmarking
      • 5.3.14.4. Strategic initiatives
    • 5.3.15. Medtronic
      • 5.3.15.1. Company overview
      • 5.3.15.2. Financial performance
      • 5.3.15.3. Product benchmarking
      • 5.3.15.4. Strategic initiatives
    • 5.3.16. Boston Scientific Corporation
      • 5.3.16.1. CompanOverviewew
      • 5.3.16.2. Financial performance
      • 5.3.16.3. Product benchmarking
      • 5.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. Medical Device Manufacturers market revenue estimates and forecast, by application, 2018 - 2030 (USD Billion)
  • Table 4 Key companies undergoing acquisitions/expansions
  • Table 5 Key companies undergoing product launch/approval
  • Table 6 Key companies undergoing partnership & collaboration

List of Figures

  • Fig. 1 U.S. Medical Device Manufacturers Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Competitive landscape
  • Fig. 9 Market Dynamics
  • Fig. 10 U.S. Medical Device Manufacturers market: PORTER's analysis
  • Fig. 11 U.S. Medical Device Manufacturers market: PESTEL analysis
  • Fig. 12 U.S. Medical Device Manufacturers market: by application: key takeaways
  • Fig. 13 U.S. Medical Device Manufacturers market, by application: market share, 2024 & 2030
  • Fig. 14 Orthopedic devices market, 2018 - 2030 (USD Billion)
  • Fig. 15 Cardiovascular devices market, 2018 - 2030 (USD Billion)
  • Fig. 16 Neurology devices market, 2018 - 2030 (USD Billion)
  • Fig. 17 Drug delivery devices market, 2018 - 2030 (USD Billion)
  • Fig. 18 Ophthalmic devices market, 2018 - 2030 (USD Billion)
  • Fig. 19 Nephrology and urology devices market, 2018 - 2030 (USD Billion)
  • Fig. 20 Others market, 2018 - 2030 (USD Billion)
  • Fig. 21 Key company categorization
  • Fig. 22 Heat map analysis
  • Fig. 23 U.S orthopedic devices market share analysis, 2024
  • Fig. 24 U.S cardiac care devices market share analysis, 2024
  • Fig. 25 U.S drug delivery devices market share analysis, 2024
  • Fig. 26 Strategic Framework